XML 68 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
Fair value of financial instruments and investments - Narrative (Details)
12 Months Ended
Dec. 31, 2018
USD ($)
$ / shares
Aug. 23, 2018
USD ($)
Dec. 31, 2017
USD ($)
$ / shares
Aug. 31, 2015
USD ($)
Financial assets and liabilities measured at fair value on recurring basis        
Marketable securities $ 58,088,000   $ 79,454,000  
Deferred consideration payable- long-term 18,300,000   0  
Contingent consideration payable 310,240,000   0  
Deferred consideration payable- current 19,400,000   0  
3.00% Convertible senior notes due 2022 | Convertible debt        
Financial assets and liabilities measured at fair value on recurring basis        
Principal 150,000,000   150,000,000 $ 150,000,000
Interest rate       3.00%
Debt instrument 146,600,000   115,700,000  
Warrants        
Financial assets and liabilities measured at fair value on recurring basis        
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $ 0   $ 1,000  
Warrants | Minimum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input | $ / shares 128.00   128.00  
Warrants | Maximum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input | $ / shares 2,520.00   2,520.00  
Warrants | Volatility | Minimum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.59   0.69  
Warrants | Volatility | Maximum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.60   0.69  
Warrants | Risk free interest rate | Minimum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.03   0.02  
Warrants | Risk free interest rate | Maximum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.03   0.02  
Warrants | Expected life | Minimum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.59   1.59  
Warrants | Expected life | Maximum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.72   1.70  
Stock Appreciation Rights (SARs)        
Financial assets and liabilities measured at fair value on recurring basis        
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $ 3,814,000   $ 1,665,000  
Stock Appreciation Rights (SARs) | Minimum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input | $ / shares 6.76   6.76  
Stock Appreciation Rights (SARs) | Maximum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input | $ / shares 30.86   30.86  
Stock Appreciation Rights (SARs) | Volatility | Minimum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.47   0.31  
Stock Appreciation Rights (SARs) | Volatility | Maximum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.60   0.70  
Stock Appreciation Rights (SARs) | Risk free interest rate | Minimum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.02   0.01  
Stock Appreciation Rights (SARs) | Risk free interest rate | Maximum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.03   0.02  
Stock Appreciation Rights (SARs) | Expected life | Minimum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 0.01   0.00  
Stock Appreciation Rights (SARs) | Expected life | Maximum        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input 1.01   2.00  
Common stock | Warrants | Fair value of common stock        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input | $ / shares 34.32   16.68  
Common stock | Stock Appreciation Rights (SARs) | Fair value of common stock        
Financial assets and liabilities measured at fair value on recurring basis        
Alternative Investment, Measurement Input | $ / shares 34.32   16.68  
Fair Value, Measurements, Recurring | Fair Value, Inputs, Level 2        
Financial assets and liabilities measured at fair value on recurring basis        
Marketable securities $ 58,088,000   $ 79,454,000  
Deferred consideration payable 37,700,000      
Warrant liability 0   0  
Stock appreciation rights liability 0   0  
Contingent consideration payable 0      
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value 0      
Agilis        
Financial assets and liabilities measured at fair value on recurring basis        
Development milestone payment obligations $ 40,000,000 $ 40,000,000    
Deferred consideration payable   38,100,000    
Agilis | Minimum        
Financial assets and liabilities measured at fair value on recurring basis        
Percentage of annual net sales 200.00%      
Agilis | Maximum        
Financial assets and liabilities measured at fair value on recurring basis        
Development milestone payment obligations $ 60,000,000.0      
Priority review voucher amount 535,000,000.0      
Net sales milestones $ 150,000,000      
Percentage of annual net sales 600.00%      
Non-collaborative Arrangement Transactions | Agilis        
Financial assets and liabilities measured at fair value on recurring basis        
Development milestone payment obligations $ 40,000,000 $ 40,000,000    
Total | Fair Value, Measurements, Recurring        
Financial assets and liabilities measured at fair value on recurring basis        
Marketable securities 58,088,000   79,454,000  
Deferred consideration payable 37,700,000      
Warrant liability 0   1,000  
Stock appreciation rights liability 3,814,000   $ 1,665,000  
Contingent consideration payable 257,040,000      
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $ 53,200,000